MAPK信号的差异性活动定义了胰腺癌中的纤维细胞亚型
Lisa Veghini1, Davide Pasini1, Rui Fang2,3
1Department of Engineering for Innovation Medicine, University of Verona, Verona, Italy.
Nature communications
|December 3, 2024
概括
在胰腺癌中,MAPK信号通路影响癌症相关纤维细胞 (CAF) 现型. 向这些肌纤维细胞CAF可能会提供一种新的抗癌治疗策略.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 癌症研究 癌症研究
背景情况:
- 纤维细胞异质性对癌症进展至关重要,需要绘制有效疗法的地图.
- 与癌症相关的纤维细胞 (CAFs) 在胰腺管腺癌 (PDAC) 中丰富,但其由PDAC细胞的表型特异性尚不清楚.
研究的目的:
- 研究MAPK信号通路在定义PDAC CAF表型中的作用.
- 描述MAPK高CAF (mapCAF) 现型及其与瘤特征和治疗反应的关联.
主要方法:
- 从小鼠模型中整合单细胞剖析与人类组织细胞和空间剖析.
- 在干扰后对转录反应的分析.
- 评估基因表达特征,包括MAPK活性,TGF-β信号传递,缺氧和免疫调节.
主要成果:
- 表皮MAPK活性通过TGF-β1.1.驱动CAFs的肌纤维细胞分化.
- 定义了一个MAPK高CAF (mapCAF) 现型,与基底类瘤细胞和较少的CD8+ T细胞相关.
- 在癌症中,mapCAF签名富含肌纤维细胞CAF,并且与黑色素瘤中免疫检查点抑制的反应减少有关.
结论:
- MAPK途径是PDAC中CAF表型异质性的关键决定因素.
- 地图CAF表型的特点是特定的信号通路和免疫特征.
- 向肌纤维细胞CAF是各种癌症类型的潜在治疗策略.
相关概念视频
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
MAPK Signaling Cascades
5.2K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.2K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K


